chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red, blotchy, & itchy rash on the tops of my hands, tops of my feet; Red, blotchy, & itchy rash on the tops of my hands, tops of my feet; Swelling of both my hands and feet; Swelling in the joints of both my hands; High temperature; Was achy; Low back pain; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (Was achy), BACK PAIN (Low back pain), RASH PRURITIC (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), RASH ERYTHEMATOUS (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet) and PERIPHERAL SWELLING (Swelling of both my hands and feet) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN (Was achy), BACK PAIN (Low back pain) and PYREXIA (High temperature). On 05-Mar-2021, the patient experienced RASH PRURITIC (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), RASH ERYTHEMATOUS (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), PERIPHERAL SWELLING (Swelling of both my hands and feet) and JOINT SWELLING (Swelling in the joints of both my hands). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, PAIN (Was achy), BACK PAIN (Low back pain), RASH PRURITIC (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), RASH ERYTHEMATOUS (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), PERIPHERAL SWELLING (Swelling of both my hands and feet), JOINT SWELLING (Swelling in the joints of both my hands) and PYREXIA (High temperature) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   This case was linked to MOD-2021-059980 (Patient Link).
Temp to 103 Pain and redness in arm 7 x 8 cm area on deltoid tender, indurated. Also complained of headache, given Tylenol without much relief. Arm involved left. Recovering area still red, indurated. Information from 60 day follow-up report states: This patient has not had any contact with our facility since 10/24/05.  Follow-Up Info: No problems related to Vaccine
Patient developed mandibular tooth pain described as a constant severe throb/ache involving the entire mandible as well as nausea, and extreme fatigue the day after receiving the second HPV vaccine on 1/4/11.
48 y/o female received 1st dose Pfizer Vaccine (Lot # ER8732 Exp: 3/28/2021) @ 1234 on left deltoid. RN explained risks/benefits of vaccine and received verbal consent to administer vaccine. Past medical history includes allergies to codeine and sulfa drugs. At 1242, patient at EMT station complaining of a "jolt" and itchy scalp. EMTs responded. Patient alert and oriented x4. At 1250, patient moved to zero gravity chair, unassisted. Ice pack placed against posterior of neck. Vitals signs taken every 7 mins. At 1253: BP 148/88, HR 70, RR 12; patient reports ?no more itchy scalp? but has a headache, 3/10 pain, constant, states "feels like weight on head". At 1300: BP 138/98, HR 62, RR 16; patient reports itchy scalp has resolved. Patient reports only headache. At 1307: BP 130/90, HR 68, RR 18; patient reports feeling better. Offered EMS services and patient declined. Pt completed recommended 30 minute observation. Pt left on own will and was ambulatory at 1312. Patient left building without assistance and with a steady gait.
Heavy break through bleeding. I was on my regular menstrual cycle last week, so this period is not normal.; Heavy break through bleeding. I was on my regular menstrual cycle last week, so this period is not normal.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 14Apr2021 at 14:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included progesterone (MANUFACTURER UNKNOWN) for birth control from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 16:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 05:00, the patient experienced heavy break through bleeding, she was on her regular menstrual cycle last week, so this period was not normal. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events heavy break through bleeding, she was on her regular menstrual cycle last week, so this period was not normal was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Patient received first dose of Pfizer at 1410. RN sat with patient for observation because of anaphylactic reaction to hydrocodone. 1428  patient patient given water and juice. 1430 patient feeling nauseated, assisted to wheelchair then to gurney and laid down. 1440 blood pressure 190/100 HR 101 oxygen saturation 98 .1442 blood pressure 192/118 patient denies history of hypertension complains of tightness in chest, reports history of anxiety ?this is how it felt before I think it?s my anxiety ?1450 medicated with Benadryl 25 mg wife arrived at 1445 to be at bedside informed of status. 1454 sat patient up on side of gurney BP 160/ 98 HR  93  O2sat 96%. Patient continues  to feel tight in middle of chest pointing to his mid sternum. Patient  became dizzy and chills after drinking cold water. 1510 laid patient back down on gurney complain of 3/ 10 pain mid sternum. At 15 03 BP 158/94 HR 80 O2 sat 99%1518 EMS called 1528 EMS arrived evaluation done, patient refused EMS transport wife drove patient to ER at 1542
Headache, Fever & Tachycardia Narrative: Prior diagnosis of Covid-19 on 12-10-20. Reports having a headache when she received the vaccine. Later that evening her headache intensified into a migraine with blurred vision, left ear tinnitus the loss of hearing in left ear. She also reports tachycardia and temp of 100.2. She reports being treated with 2L NS, Torodal, solumedrol, and Ketamine. Treated at another facility, exact doses unknown.
1st dose put in left arm front not side where it should have been given, extremely painful during injection but only sore for next few days. Second dose given by same person. Was asked by me to please put on the side but was ignored and again put in front part of arm not where it belongs. Was painful for a few days and some fatigue but was ok for about a week. About 8-10 days after injection arm became extremely painful at injection site and has gotten worse. pain radiates down arm into elbow and hand. Arm is basically useless as the pain is extreme upon any use. Some swelling around where injection site is but no rash or soreness.
Arrhythmia started the evening I received the Moderna COVID-19 booster shot.
PATIENT STATES THAT AFTER ABOUT 2-3 HOURS OF VACCINATION STARTED TO HAVING SOME SWELLING IN HER LEFT ANKLE .  SHE STATES THAT THE SWELLING WAS VERY BAD.
Patient presented with weakness and cough. Patient is fully vaccinated and ended up being positive for COVID-19.
Swelling, pain and redness at site of injection, persited for 48 hours, no specific treatment.
Immediate pain and soreness in left arm, continued to get worse for 36 hours then subsided; other symptoms occurred after 12 hours- terrible headache, extreme fatigue and exhaustion, chills, extreme body aches, joint pain/aches all over, slight fever around 99-100, decreased appetite
Vomiting once 5 hrs after shot Nausea ongoing 48 hrs Fever 100.7 ongoing for 24 hrs Severe headache ongoing for 24 hrs Body aches ongoing for 24 hrs Fatigue ongoing for 24 hrs Pain at injection site ongoing for 72 hrs Took 2 Tylenol every 6-8 hours for 24 hrs
10:05 Anaphylaxis  ( coughing, swelling, hives, belly pain),  10:15 AM sent her to ER and gave her EPIPEN JR. 11:08 AM gave her dexamethasone and 11:32 AM gave her famotidine
had a slightly elevated temperature; a little off; Initial information was received on 10-Oct-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional (patient) via social media.  This case involves 56 years old female patient who had a slightly elevated temperature (body temperature increased) and was a little off (mood altered), while she received INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient had a slightly elevated temperature (body temperature increased) and was a little off (mood altered) (unknown latency, non-serious event) following the administration of INFLUENZA VACCINE.  As a healthcare professional she was required to take the vaccine a few times. She said that she will not take vaccine again.   No laboratory data was provided.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case
Itch in the Injection site (IS); burning IS; Redness IS; Hardness IS; Sore Arm; A spontaneous report was received from a Consumer concerning a 81-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events itch in the injection site (is), burning is, redness is, hardness is, sore arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 13 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 029L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 25 Jan 2021, the patient experienced the events itch in the injection site (is). burning is, redness is, hardness is, sore arm.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, itch in the injection site (is), On an unknown date the outcome of events, burning is, On an unknown date the outcome of events, redness is, On an unknown date the outcome of events, hardness is, On an unknown date the outcome of events, sore arm was not reported.
I experienced severe headaches for several days after receiving the vaccine booster. I had a tele-medicine appointment with my PCP on 11/09/2021 and she wants me to get a COVID-19 test and placed me on a beta blocker medication Propranolol to help with the Migraine headaches to see if that would resolve my symptoms (started 11/10/2021).
On 20Mar2021, she had pain in left knees, left leg and left calf.; On 20Mar2021, she had pain in left knees, left leg and left calf.; On 20Mar2021, she had pain in left knees, left leg and left calf.; Patient started getting aches in her legs, and arms next day after receiving 2nd dose; Patient started getting aches in her legs, and arms next day after receiving 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of PAIN IN EXTREMITY (Patient started getting aches in her legs, and arms next day after receiving 2nd dose), the second episode of PAIN IN EXTREMITY (Patient started getting aches in her legs, and arms next day after receiving 2nd dose), the first episode of PAIN IN EXTREMITY (On 20Mar2021, she had pain in left knees, left leg and left calf.), the second episode of PAIN IN EXTREMITY (On 20Mar2021, she had pain in left knees, left leg and left calf.) and ARTHRALGIA (On 20Mar2021, she had pain in left knees, left leg and left calf.) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 19-Mar-2021, the patient experienced the first episode of PAIN IN EXTREMITY (Patient started getting aches in her legs, and arms next day after receiving 2nd dose) and the second episode of PAIN IN EXTREMITY (Patient started getting aches in her legs, and arms next day after receiving 2nd dose). On 20-Mar-2021, the patient experienced the first episode of PAIN IN EXTREMITY (On 20Mar2021, she had pain in left knees, left leg and left calf.), the second episode of PAIN IN EXTREMITY (On 20Mar2021, she had pain in left knees, left leg and left calf.) and ARTHRALGIA (On 20Mar2021, she had pain in left knees, left leg and left calf.). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, last episode of PAIN IN EXTREMITY (Patient started getting aches in her legs, and arms next day after receiving 2nd dose), the last episode of PAIN IN EXTREMITY (On 20Mar2021, she had pain in left knees, left leg and left calf.) and ARTHRALGIA (On 20Mar2021, she had pain in left knees, left leg and left calf.) outcome was unknown.            Concomitant medications included DIABETIC medication (NOS) and CHEMOTHERAPY (NOS).   Action taken with mRNA-1273 in response to the events was not Applicable.  Patient consents to contact.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: email address added
intussusception confirmed by abdominal x ray, abdominal ultrasound at 10-5-07 10/22/07-records received for DOS 10/5-10/7/07-DC DX: Intussusception. Laparotomy, appendectomy. Operative reduction of intussusception. Hydrostatically irreducible. Three days prior to admission C/O abdominal pain and emesis, HX of episodic pain, no bloody bowel movements.
Chest discomfort, rapid heart rate, shortness of breath, fatigue, and exercise intolerance for 2-3 weeks following the first dose.
This case was reported in a literature article and described the occurrence of vomiting in a 7-year-old male patient who received Influenza vaccine. On an unknown date, the patient received Influenza vaccine (unknown). On an unknown date, 3 days after receiving Influenza vaccine, the patient experienced vomiting, appetite lost and influenza A virus infection. On an unknown date, the outcome of the vomiting, appetite lost and influenza A virus infection were unknown. The reported cause of death was Reye's syndrome. An autopsy was performed. The autopsy determined cause of death was hepatic steatosis, kidney tubule disorder, cerebral edema, influenza A virus infection and salicylate intoxication. It was unknown if the reporter considered the vomiting, appetite lost and influenza A virus infection to be related to Influenza vaccine. Additional information received: This case was reported in a literature article and it described the occurrence of vomiting in a 7-year-old male patient who had received unspecified influenza A vaccination (manufacturer unknown). No information on the patient's medical or family history or concurrent condition was provided. On an unspecified date, the patient received unspecified influenza A vaccine (administration route and site unspecified; dosages unknown; batch numbers not provided). On an unspecified date, 3 days after receiving vaccination the patient developed profound vomiting and loss of appetite. The patient's mother had given him PEPTO-BISMOL and Gatorade as treatment and sent the patient to bed. The patient was found unresponsive less than 12 hours later and pronounced dead 4 minutes after arrival at the hospital. Autopsy findings included diffuse mixed micro and macro vesicular steatosis of the liver, micro vesicular steatosis in the renal tubule cells, and cerebral edema. A postmortem nasopharyngeal swab screening was positive for influenza A. Toxicology was positive for salicylate. The outcomes of the events were unspecified. The authors did not comment on causality relationship between the vaccine and the event. The authors concluded that "Reye's syndrome is a rare severe neurologic disorder consisting of a biphasic illness characterized by a viral infection followed by an acute onset of non-inflammatory encephalopathy and hepatic failure, with rapid progression to death if not properly treated. It most commonly affects children younger than 16 years of age who are treated with aspirin during certain viral infections, including varicella and influenza. The exact cause is unknown, but it is thought to result from mitochondrial impairment resulting from the actions of salicylate and its metabolites, hydroxyhippurate and gentisate. This impairment appears to be intensified during viral illnesses".
broke out w/bright red elevated rash all over body;itched;gave DPH & Rhuli gel;redness went away;returned in AM, did same tx 10AM went completely away until about 5PM;took DPH;swelling of feet & ankles, hands & cheeks;
Patient became nauseas, pale, diaphoretic after recieving vaccine.  Vitals were low normal, BP: 90/50 , pulse  of 53 bmp and pusle ox of 98% on room air. Patient remained alert and oriented at all times, did not become consiousness at any time. EMS called, patients vitals improved, refused transport. Driver with patient.
The patient came into report that the ZOSTAVAX she received on 6/2/11 caused her to break out in a shingles-type rash about 1 week later about 6/29/11. She said that her doctor said it was a mild case of shingles & gave her a prescription for an antiviral medication for 10 days. The patient stated at the time she felt completely fine now that the rash had resolved with treatment.
1/29/22 pt presents to ED via EMS with c/o dyspnea that's worsening; has been falling at home; hx of DM and HTN; placed on CPAP; high blood glucose; DKA; transferred to ICU; found to be positive for COVID; asymptomatic; given ABX; suffered strokes and cerebral edema; condition worsened; determined brain dead by flow study; DC and med records sent t per VAERS request
I contracted COVID-19 on 05/16/2022 with sore throat, cough, a mild fever, and  fatigue. I did a COVID-19 rapid nasal swab that was negative on 05/16/2022, and after my daughter tested positive I also had another COVID-19 rapid nasal swab that was positive on 05/18/2022. I began to feel better on 05/18/2022 after I was prescribed Paxlovid the morning I tested positive. My symptoms have resolved as of today 05/20/2022, with no lingering symptoms.
Pain in the arm where I got the shot about 2 hours after receiving the vaccine,  Chills after 10 hours,  Fever and Headache after 12 hours,  Tiredness and Fainted on the 2nd day
sore arm; mild headache.; This is a spontaneous report received from a contactable consumer. A female patient of unknown age, received adalimumab (HUMIRA, solution for injection in pre-filled syringe and pen) from unknown date, subcutaneous for Psoriatic Arthritis. Covid-19 vaccine  was also considered suspect. Patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number unknown), via an unspecified route of administration on unknown date at single dose for COVID-19 immunization. Patient experienced headache and sore arm. Outcome of events was unknown.  No follow up attempts are possible. Information related to batch/lot number could not be requested
In your shot. 1. 100 temp 2. 101 temp 3. 102 temp for 4 days; I was so sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; LOT NUMBER: UNKNOWN), for Covid-19 immunization; Bnt162b2 (DOSE 2, SINGLE; LOT NUMBER: UNKNOWN), for COVID-19 Immunization. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "In your shot. 1. 100 temp 2. 101 temp 3. 102 temp for 4 days"; ILLNESS (non-serious), outcome "unknown", described as "I was so sick". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient reported that patient had trouble with the 3 shots. Was there eggs, milk products and aluminum die. Patient had shot. 1. 100 temp 2. 101 temp 3. 102 temp for 4 days and stated that so sick that I a, scared to get a booster shot.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Rash around injection site. About 2? around. Expanded to 3? around. Rash cleared in the middle and a circular outline formed over 8 days and dispersed.
I have blood in my urine; This is an initial spontaneous report from a contactable consumer (patient). A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection) via an unspecified route of administration on 21Apr2021 16:00 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. He got the second covid shot yesterday at 4PM and he have blood in urine today. He have no other symptoms.   Follow-up activities has been raised. Information on the lot/batch number has been requested.
Received rabies vaccines 8/15 and had arm/shoulder and arm lymphadenopathy starting 8/16/02 in the evening. Maximum edema, lymphadenopathy at 48 hours.
Moderna Bivalent Booster 0.25mcg was given not 0.5mcg, wrong dose was given to patient.
non-aural vertigo; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: Unknown), via an unspecified route of administration on an unspecified date, as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: Unknown), via an unspecified route of administration on an unspecified date, as single dose for COVID-19 immunisation. On an unspecified date, approximately 2 months after receiving the second dose of Pfizer COVID 19 vaccine, the patient experienced non-aural vertigo. The clinical outcome of the event was unknown.  Information on the lot/batch number has been requested.